wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42505092-0BA7B2F0-E615-49FC-835B-5B336AB182FB
Q42505092-0BA7B2F0-E615-49FC-835B-5B336AB182FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42505092-0BA7B2F0-E615-49FC-835B-5B336AB182FB
A phase I clinical trial demonstrates that nfP2X7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma.
P2860
Q42505092-0BA7B2F0-E615-49FC-835B-5B336AB182FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42505092-0BA7B2F0-E615-49FC-835B-5B336AB182FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d321c74b257c4818e915f26aabf12514c4f26d67
P2860
Advances in the management of basal cell carcinoma.